(R)-N-(2-(benzylthio)ethyl)-7'-(bis(3,5-di-tert-butylphenyl)phosphaneyl)-2,2',3,3'-tetrahydro-1,1'-spirobi[inden]-7-amine

Catalog No. :
ACTOIY036
CAS No. :
1809609-52-6
Molecular Formula :
C54H68NPS
Molecular Weight :
794.19

IUPAC Name:(R)-N-(2-(benzylthio)ethyl)-7'-(bis(3,5-di-tert-butylphenyl)phosphaneyl)-2,2',3,3'-tetrahydro-1,1'-spirobi[inden]-7-amine

(R)-N-(2-(benzylthio)ethyl)-7'-(bis(3,5-di-tert-butylphenyl)phosphaneyl)-2,2',3,3'-tetrahydro-1,1'-spirobi[inden]-7-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-N-(2-(benzylthio)ethyl)-7'-(bis(3,5-di-tert-butylphenyl)phosphaneyl)-2,2',3,3'-tetrahydro-1,1'-spirobi[inden]-7-amine
IUPAC Name(R)-N-(2-(benzylthio)ethyl)-7'-(bis(3,5-di-tert-butylphenyl)phosphaneyl)-2,2',3,3'-tetrahydro-1,1'-spirobi[inden]-7-amine
MDL No.-
Molecular FormulaC54H68NPS
Molecular Weight794.19
SMILESCC(C)(C)C1=CC(C(C)(C)C)=CC(P(C2=CC(C(C)(C)C)=CC(C(C)(C)C)=C2)C2=C3C(=CC=C2)CC[C@@]32CCC3=C2C(NCCSCC2=CC=CC=C2)=CC=C3)=C1
InChI KeyKCPKRTWDDWPCHY-AXAMJWTMSA-N
Synonym(R)-DTB-SpiroSAP-Bn
CAS No.1809609-52-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTOIY036 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJNRP860 route compound structure diagram
    ACJNRP8601007-54-1 In Stock
  4. Then
  5. ACTOIY036 route product structure diagram
    ACTOIY0361809609-52-6
Inquiry

2. ACTOIY036 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTOIY036 route product structure diagram
    ACTOIY0361809609-52-6
Inquiry

Comments (0)